Inventors with similar research interests:
Location History:
- University City, MO (US) (1980 - 1981)
- Lafayette, IN (US) (1984)
- West Lafayette, IN (US) (1981 - 1987)
- De Peres, MO (US) (2001)
- St. Louis, MO (US) (2002)
- Des Peres, MI (US) (2004)
- Kirkwood, MO (US) (1984 - 2005)
- Alpharetta, GA (US) (2003 - 2007)
- Des Peres, MO (US) (1997 - 2008)
- Atlanta, GA (US) (2003 - 2011)
Company Filing History:
52 out of 1,323 
30 out of 200 
23 out of 3,288 
Years Active: 1980-2011
Title: James A Sikorski: Innovative Pioneer in Pharmaceutical Patents
Introduction:
James A Sikorski, a resident of Des Peres, MO, is a brilliant inventor and researcher at the forefront of pharmaceutical innovations. With an impressive track record of 130 patents, Sikorski has made substantial contributions to the field of medicine, particularly in treating inflammatory disorders such as asthma. This article delves into his latest patents, career highlights, collaborations, and acknowledges his immense contribution to the world of pharmaceuticals.
Latest Patents:
Sikorski's recent patents demonstrate his focus on developing compounds for the treatment of inflammatory conditions and as retroviral protease inhibitors. In his patent titled "Sulfonamide Containing Compounds for Treatment of Inflammatory Disorders," he presents a series of compounds and pharmaceutical compositions for the treatment and prevention of asthma and other inflammatory conditions. These compounds, as outlined in the general Formula I, show great promise for the management of these disorders.
Another noteworthy patent by Sikorski is his innovation in retroviral protease inhibitors. In his patent on "Bis-amino Acid Hydroxyethylamino Sulfonamide Retroviral Protease Inhibitors," Sikorski introduces novel compounds, compositions, and methods for inhibiting retroviral proteases, with a particular focus on the human immunodeficiency virus (HIV) protease. This groundbreaking research offers potential avenues for preventing retroviral infection and treating existing infections caused by retroviruses.
Career Highlights:
Throughout his illustrious career, Sikorski has contributed his expertise to esteemed companies in the pharmaceutical industry. He had the opportunity to work at G.D. Searle & Company, a renowned research-based pharmaceutical corporation. Additionally, Sikorski made significant contributions at Pharmacia Corporation, a leading global pharmaceutical company. His work and dedication to innovation have undoubtedly shaped the industry's advancements in treating various health conditions.
Collaborations:
In his pursuit of scientific excellence, Sikorski has collaborated with prominent individuals in the field of pharmaceuticals. Notable among them are Richard C Durley and Balekudru Devadas. These collaborations highlight Sikorski's ability to work synergistically within research teams, exchanging knowledge and expertise to create groundbreaking pharmaceutical inventions.
Conclusion:
James A Sikorski's accomplishments as an innovative inventor and researcher are truly commendable. With an impressive portfolio of 130 patents, including his latest advancements in the treatment of inflammatory disorders and retroviral protease inhibition, Sikorski has made a significant impact on the pharmaceutical industry. His collaboration with esteemed companies like G.D. Searle & Company and Pharmacia Corporation further cements his contributions to the field. Sikorski's work serves as an inspiration to aspiring inventors and researchers, driving advancements in medical science and improving the lives of countless individuals worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.